ArrowMark Colorado Holdings’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Sell |
204,505
-1,082,207
| -84% | -$1.55M | 0.01% | 288 |
|
|
2025
Q1 | $2.06M | Sell |
1,286,712
-47,389
| -4% | -$75.8K | 0.03% | 226 |
|
|
2024
Q4 | $4.8M | Buy |
1,334,101
+14,617
| +1% | +$52.6K | 0.06% | 193 |
|
|
2024
Q3 | $7.52M | Buy |
1,319,484
+75,126
| +6% | +$428K | 0.1% | 158 |
|
|
2024
Q2 | $5.75M | Sell |
1,244,358
-47,581
| -4% | -$220K | 0.07% | 188 |
|
|
2024
Q1 | $10.6M | Sell |
1,291,939
-845,442
| -40% | -$6.91M | 0.12% | 142 |
|
|
2023
Q4 | $12.1M | Sell |
2,137,381
-239,425
| -10% | -$1.35M | 0.13% | 131 |
|
|
2023
Q3 | $4.42M | Buy |
2,376,806
+2,067,051
| +667% | +$3.84M | 0.05% | 199 |
|
|
2023
Q2 | $852K | Sell |
309,755
-6,071,125
| -95% | -$16.7M | 0.01% | 257 |
|
|
2023
Q1 | $20M | Buy |
6,380,880
+578,009
| +10% | +$1.81M | 0.23% | 88 |
|
|
2022
Q4 | $34.2M | Buy |
5,802,871
+710,896
| +14% | +$4.19M | 0.41% | 77 |
|
|
2022
Q3 | $44.7M | Sell |
5,091,975
-750,432
| -13% | -$6.58M | 0.55% | 55 |
|
|
2022
Q2 | $44.1M | Buy |
5,842,407
+3,933,384
| +206% | +$29.7M | 0.5% | 65 |
|
|
2022
Q1 | $46.3M | Buy |
1,909,023
+134,519
| +8% | +$3.26M | 0.41% | 75 |
|
|
2021
Q4 | $57.1M | Buy |
1,774,504
+259,884
| +17% | +$8.37M | 0.46% | 68 |
|
|
2021
Q3 | $67.7M | Buy |
1,514,620
+118,999
| +9% | +$5.32M | 0.53% | 59 |
|
|
2021
Q2 | $52.8M | Buy |
1,395,621
+1,144,004
| +455% | +$43.3M | 0.4% | 77 |
|
|
2021
Q1 | $9.31M | Buy |
251,617
+2,468
| +1% | +$91.3K | 0.07% | 200 |
|
|
2020
Q4 | $8.25M | Buy |
+249,149
| New | +$8.25M | 0.06% | 197 |
|